Endocrine Therapy Drugs (ETDs) Market
- 2026 年市場規模
- USD 35,300 Mn
- 2033 年預估規模
- USD 50,000 Mn
- 年複合成長率 CAGR
- 5.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Endocrine Therapy Drugs (ETDs) Market, By Drug Type (Anti-diabetic Drugs, Anti-osteoporosis Drugs, Contraceptive Drugs, Breast Cancer Drugs, Others (Menopause Drugs, among others)), By Application (Diabetes, Breast Cancer, Osteoporosis, Menopause, Contraception, Others (Gender Reassignment Surgery, Hypothyroidism, among others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
The endocrine system of the human body uses hormones to control and coordinate with the human body’s metabolism, reproduction, energy level, growth and development, as well as response for stress, injury, and mood disorders. Endocrine therapy, also known as hormone therapy, adds, blocks, or removes hormones/chemicals in order to treat diseases such as breast cancer, diabetes, etc. Estrogen and progesterone found in a woman’s body can aggravate breast cancer as these hormones help the cells grow and spread throughout the body. Two types of endocrine therapy can be used for the treatment of breast cancer, i.e. a) blocking the action of estrogen and progesterone to stop them from helping cancerous cells to grow and, b) using drugs or surgery to stop the ovary from producing estrogen and progesterone. Some of the endocrine therapy drugs used in breast cancer treatment include Abemaciclib (Verzenio), Anastrozole (Arimidex), Exemestane (Aromasin), and Fulvestrant (Faslodex), among others.
Market Dynamics
The increasing prevalence of chronic diseases such as diabetes, breast cancer, and others, rising research and development activities to develop novel endocrine therapy drugs (ETDs), and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global endocrine therapy drugs (ETDs) market over the forecast period.
For instance, according to the International Federation of Diabetes Atlas 2019, around 463 million people aged 20-79 years and 136 million people aged 65 are estimated to be suffering from diabetes in 2019, globally. Moreover, according to the International Diabetes Federation Diabetes Atlas 2019, the prevalence of diabetes in Costa Rica is predicted to increase form 9.1 in 2019 to 10.3 by 2030.
Key features of the study
• This report provides an in-depth analysis of the global endocrine therapy drugs (ETDs) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global endocrine therapy drugs (ETDs) market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Novo Nordisk A/S, AstraZeneca, Generex Biotechnology, Orion Pharma AB, Sanofi, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co.,Inc., Bayer AG, Eli Lilly and Company, Abbott, Tonghua Dongbao Pharmaceutical Co., Ltd., Merck & Co., Inc., TherapeuticsMD, Inc., Pfizer Inc., Allergan, BioSante Pharmaceuticals, Amgen Inc., Noven Pharmaceuticals, Inc., and QuatRx Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global endocrine therapy drugs (ETDs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine therapy drugs (ETDs) market
Market Segmentation
• By Drug Type
o Anti-diabetic Drugs
o Anti-osteoporosis Drugs
o Contraceptive Drugs
o Breast Cancer Drugs
o Others (Menopause Drugs, among others)
• By Application
o Diabetes
o Breast Cancer
o Osteoporosis
o Menopause
o Contraception
o Others (Gender Reassignment Surgery, Hypothyroidism, among others)
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Novo Nordisk A/S
o AstraZeneca
o Generex Biotechnology
o Orion Pharma AB
o Sanofi
o Teva Pharmaceutical Industries Ltd.
o Hoffmann-La Roche
o Hisamitsu Pharmaceutical Co.,Inc.
o Bayer AG
o Eli Lilly and Company
o Abbott
o Tonghua Dongbao Pharmaceutical Co., Ltd.
o Merck & Co., Inc.
o TherapeuticsMD, Inc.
o Pfizer Inc.
o Allergan
o BioSante Pharmaceuticals
o Amgen Inc.
o Noven Pharmaceuticals, Inc.
o QuatRx Pharmaceuticals
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o PEST Analysis
o Regulatory Scenario
o Market Trends
o Key Highlights
o Reimbursement Scenario
o Mergers & Acquisitions
o Epidemiology
4. Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Anti-diabetic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Anti-osteoporosis Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Contraceptive Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Breast Cancer Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others (Menopause Drugs, among others)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Endocrine Therapy Drugs (ETDs) Market, By Application, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Osteoporosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Menopause
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Contraception
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others (Gender Reassignment Surgery, Hypothyroidism, among others)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Endocrine Therapy Drugs (ETDs) Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
o North America
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Novo Nordisk A/S
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AstraZeneca
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Generex Biotechnology
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Orion Pharma AB
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
F. Hoffmann-La Roche
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hisamitsu Pharmaceutical Co.,Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bayer AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Abbott
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Tonghua Dongbao Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & Co., Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
TherapeuticsMD, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Allergan
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
BioSante Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amgen Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Noven Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
QuatRx Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們